Samuel T. Wilkinson, MD
Advertisement
Articles by Samuel T. Wilkinson, MD
Experts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.
What is the efficacy of ECT for the treatment of dementia?
Samuel T. Wilkinson, MD, discusses the risks and benefits, as well as the challenges of clinical implementation of esketamine, for treatment-resistant depression.
Advertisement
Latest Updated Articles
The Effects of Multidose Ketamine Treatment on Cognitive Performance Over Time in Patients With TRDPublished: June 25th 2024 | Updated:
What Is the Deal With Esketamine?Published: April 6th 2020 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
ADHD Found Connected to Substance Use Disorder, With Sex Prevalence Differences
2
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
3
Sleep as Connective Tissue: Quantifying Team Dynamics in Elite Sports
4
A Moral Injury Update: The PNHP Study and an Imminent Step Toward Peace in the Mideast
5
